ライフサイエンスコーパス: pneumonia

1 eep vein thrombosis, pulmonary embolism, and pneumonia).

2 sitive without confirmed/suspected bacterial pneumonia).

3 001 for all comparisons to patients with CMV pneumonia).

4 eing sepsis, septic shock, viral sepsis, and pneumonia).

5 gands fibrin and histone were induced during pneumonia.

6 adjunct therapeutic avenue for pneumococcal pneumonia.

7 events were worsening of IPF, dyspnoea, and pneumonia.

8 lections in young children with acute severe pneumonia.

9 ew decades by two global outbreaks of deadly pneumonia.

10 dren hospitalized with severe or very severe pneumonia.

11 lator-associated pneumonia (VAP) do not have pneumonia.

12 quent bacterial infections that cause severe pneumonia.

13 diagnostic tool in epidemiologic studies of pneumonia.

14 .3% and 7.6% for AMI, and 18.3% and 8.5% for pneumonia.

15 tre identified 274 patients with ARDS due to pneumonia.

16 atous lymphadenitis, and bronchointerstitial pneumonia.

17 of noninvasive ventilation in patients with pneumonia.

18 kely to have signs typically associated with pneumonia.

19 n did not affect any of the responses during pneumonia.

20 the myocardium of all NHPs with acute severe pneumonia.

21 criteria to identify patients with suspected pneumonia.

22 llion children under the age of 5 years from pneumonia.

23 atory tract colonizers and pathogen-specific pneumonia.

24 roles of these toxins in the pathogenesis of pneumonia.

25 iae are known to be copathogens in childhood pneumonia.

26 R-P. aeruginosa infections, most of whom had pneumonia.

27 ntibiotic therapy, in an NHP model of severe pneumonia.

28 hildren hospitalized with community-acquired pneumonia.

29 e synergy is essential for the resolution of pneumonia.

30 as a useful diagnostic tool for pneumococcal pneumonia.

31 es a novel therapeutic approach to influenza pneumonia.

32 limited by lack of a gold standard for viral pneumonia.

33 th the same parameters in community-acquired pneumonia.

34 s, dehydration, heart failure, and bacterial pneumonia.

35 eases (COPDs) such as asthma, bronchitis, or pneumonia.

36 ad pneumonia (84.1%), of whom 35% had severe pneumonia.

37 survival in patients with severe ARDS due to pneumonia.

38 ia and identified 2156 cases of radiological pneumonia.

39 mouse disease model of aspergillus fumigatus pneumonia.

40 discharge diagnosis of SCD and either ACS or pneumonia.

41 to meropenem in the treatment of nosocomial pneumonia.

42 ute myocardial infarction, heart failure, or pneumonia.

43 impact on the incidence of severe childhood pneumonia.

44 outcomes were splenic injury and aspiration pneumonia.

45 important diagnostic indicator in pediatric pneumonia.

46 es in adult patients with community-acquired pneumonia.

47 noninfected CF mice is sufficient to induce pneumonia.

48 IPF) is a progressive and fatal interstitial pneumonia.

49 ents, causing a potentially life-threatening pneumonia.

50 rtality among patients who were admitted for pneumonia (-0.431 percentage points [95% CI, -0.714 to -

51 0-1.6 log10 IU/mL] for patients with non-CMV pneumonia, 0 log10 IU/mL [IQR, 0-1.6 log10 IU/mL] for pa

52 I, -0.003% (95% CI, -0.005% to -0.001%); and pneumonia, 0.001% (95% CI, -0.001% to 0.003%).

53 6); AMI, 0.067 (95% CI, 0.027 to 0.106); and pneumonia, 0.108 (95% CI, 0.079 to 0.137).

54 mbocytopenia (each 14%), diarrhea (11%), and pneumonia (10%).

55 delalisib plus ofatumumab group and included pneumonia (23 [13%] patients in the idelalisib plus ofat

56 were unspecified clinical sepsis (25.5%) and pneumonia (24.8%).

57 sepsis (36 [14%]; two related to treatment), pneumonia (27 [11%]), acute renal failure (25 [10%]; fiv

58 cytopenia (33 [13%]), sepsis (28 [11%]), and pneumonia (27 [11%]).

59 diac failure (5 [2%]), pyrexia (4 [2%]), and pneumonia (4 [2%]) with pacritinib, and anaemia (5 [5%])

60 0-21.8) for exacerbations, 2.8 (2.4-3.3) for pneumonia, 4.3 (2.8-6.7) for death from respiratory caus

61 group), hypertension (67 [15%] vs 15 [3%]), pneumonia (42 [9%] vs 39 [9%]), thrombocytopenia (41 [9%

62 es (19 [40%]), hyperglycemia (12 [25%]), and pneumonia (7 [15%]).

63 1.5%), or fibrosing nonspecific interstitial pneumonia (7.2%).

64 HIV-negative cases with confirmed bacterial pneumonia, 77% had CRP >/=40 mg/L compared with 17% of 5

65 ong these patients, 132 (58%) presented with pneumonia, 78 (35%) presented with meningitis, and 16 (7

66 Most RSV inpatients had pneumonia (84.1%), of whom 35% had severe pneumonia.

67 s of measles affect most organ systems, with pneumonia accounting for most measles-associated morbidi

68 r thin lung tissue sections in murine fungal pneumonia achieved sensitivity/specificity 0.99/0.98 in

69 to identify diagnostic studies of pediatric pneumonia across a broad age range that had to include c

70 justed time to event analyses, patients with pneumonia + acute kidney injury were most likely to die

71 In 2012, cases of lethal pneumonia among Chinese miners prompted the isolation of

72 atients with documented bacterial aspiration pneumonia among comatose ICU patients with symptoms sugg

73 t modest reductions in hospitalised cases of pneumonia and a marked impact on the incidence of severe

74 on-LCI clinical outcomes including all-cause pneumonia and acute otitis media.

75 Organization-defined severe and very severe pneumonia and age-matched community controls.

76 esistance to many antimicrobial agents, with pneumonia and bacteremia as the most common manifestatio

77 ton pump inhibitors on ventilator-associated pneumonia and C. difficile remain unclear.

78 IS specimens from children with radiographic pneumonia and children with suspected pneumonia but with

79 ratory disorders (2662 [12%] deaths), mainly pneumonia and chronic obstructive airways disease.

80 nths hospitalized with severe or very severe pneumonia and community controls of the same age without

81 Organization-defined severe and very severe pneumonia and from controls in 9 diverse sites in 7 low-

82 e investigated 18 833 children with clinical pneumonia and identified 2156 cases of radiological pneu

83 ) is the leading cause of community-acquired pneumonia and is now recognized to be a direct contribut

84 ly correlated with radiographic suspicion of pneumonia and less so with results of the RVP.

85 sitively associated with confirmed bacterial pneumonia and negatively associated with RSV pneumonia i

86 ung neutrophils in mice during S. pneumoniae pneumonia and performed in depth in silico analyses.

87 lung aspirates from radiologically confirmed pneumonia and postmortem examinations.

88 ublic health problems, including meningitis, pneumonia and septicaemia.

89 monitoring of children with chest indrawing pneumonia and signs of severe respiratory distress, oxyg

90 from six adult NHPs with severe pneumococcal pneumonia and three uninfected control animals.

91 nity controls of the same age without severe pneumonia and were tested with an extensive array of lab

92 hospitalized with radiographically confirmed pneumonia and who received beta-lactam monotherapy or be

93 15 for mortality among patients admitted for pneumonia) and control hospitals (number of hospitals ra

94 itive in a small proportion of children with pneumonia) and/or specificity (eg, detection of pathogen

95 reatinine values: 1) acute kidney injury, 2) pneumonia, and 3) pneumonia with acute kidney injury.

96 or attenuating the risk of childhood asthma, pneumonia, and bronchiolitis in genetically susceptible

97 with Candida albicans, disseminated disease, pneumonia, and cardiovascular disease were significantly

98 nfarction, congestive heart failure, stroke, pneumonia, and chronic obstructive pulmonary disease) an

99 COPD had an increased risk of exacerbations, pneumonia, and death.

100 sonal history of cancer, personal history of pneumonia, and family history of lung cancer.

101 3 adverse events (AEs; >5%) included anemia, pneumonia, and fatigue.

102 de 3 thyroiditis, grade 3 hepatitis, grade 3 pneumonia, and grade 4 myocarditis).

103 score II, diagnosis of ventilator-associated pneumonia, and infection by multidrug-resistant bacteria

104 y manifests as sepsis, ventilator-associated pneumonia, and infection of surgical sites and indwellin

105 re virulent than ST618 in models of invasive pneumonia, and is carried at higher densities than ST618

106 , specifically bowel perforation, aspiration pneumonia, and splenic injury.

107 eceived deferred treatment (aortic aneurysm, pneumonia, and unknown cause); all four deaths were cons

108 fection; ICU-acquired bloodstream infection, pneumonia, and urinary tract infection; all-cause ICU mo

109 te changes in hospitalizations for all-cause pneumonia associated with the introduction of pneumococc

110 We found an inverse relationship between pneumonia-associated invasive pneumococcal serotypes and

111 y 1 dose-limiting toxicity reported (grade 3 pneumonia at 20 mg/kg QW/Q2W); the MTD was not reached.

112 A overexpression is an associated factor for pneumonia, bacteremia, and death due to A. baumannii.

113 production was a risk factor associated with pneumonia, bacteremia, and mortality.

114 code 584.xx (acute kidney injury) or 486.xx (pneumonia) between October 1, 1999, and December 31, 200

115 raphic pneumonia and children with suspected pneumonia but without chest radiographic changes or clin

116 during childhood community-acquired alveolar pneumonia (CAAP).

117 ho were hospitalized with community-acquired pneumonia (CAP) and children asymptomatic at the time of

118 derstanding the burden of community-acquired pneumonia (CAP) is critical to allocate resources for pr

119 persons hospitalized with community-acquired pneumonia (CAP).

120 analysis from 3772 (89.1%) of 4232 suspected pneumonia cases enrolled in PERCH.

121 Although we found higher viral loads among pneumonia cases than controls for some viruses, the util

122 Prior to PCV introduction, at least 53% of pneumonia cases were due to pneumococci in HIV-infected

123 Clinically diagnosed pneumonia cases with abnormal CXRs were more likely to h

124 ographs (CXRs) are frequently used to assess pneumonia cases.

125 CRP >/=40 mg/L compared with 17% of 556 RSV pneumonia cases.

126 After 1950, the proportion of pneumonia caused by pneumococcus began to decline.

127 Legionnaires' disease is a severe form of pneumonia caused by the bacterium Legionella pneumophila

128 l pneumonia (including ventilator-associated pneumonia) caused by Gram-negative pathogens.

129 ting depression, lupus erythematosus, recent pneumonia, chronic kidney disease, and active cancer, bu

130 litus in a large European community-acquired pneumonia cohort.

131 ly in the IS specimens from the radiographic pneumonia compared with the nonpneumonia cases.

132 l pneumonia, including ventilator-associated pneumonia, compared with meropenem in a multinational, p

133 ia included in the German Community-Acquired Pneumonia Competence Network (CAPNETZ) study between 200

134 defined as a composite endpoint of bacterial pneumonia (confirmed by the endpoint review committee),

135 ung neutrophils from mice with S. pneumoniae pneumonia contained 4127 DE mRNAs, 36% of which were upr

136 argeted enrollment of marginal patients with pneumonia could enrich future randomized trials.

137 such as acute respiratory distress syndrome, pneumonia, cystic fibrosis, and bronchiectasis.

138 zard models to assess risk of exacerbations, pneumonia, deaths due to respiratory causes, and deaths

139 Pneumococcal pneumonia declined from 2.9 to 1.2 cases per 1000 person

140 Hospitalization rates of PCV13 serotype pneumonia decreased from 47.2 to 15.7 per 100000 admissi

141 or myocardial infarction, heart failure, and pneumonia decreased more rapidly than before the law's p

142 ected from human patients with P. aeruginosa pneumonia demonstrated cytotoxic activity, and lavage fl

143 C2, contributes to local host defense during pneumonia-derived sepsis by enhancing leukocyte function

144 bsiella pneumoniae via the airways to induce pneumonia-derived sepsis.

145 Ventilator-associated pneumonia developed in 20.4% of patients in the pantopra

146 city, 51%) were not strongly associated with pneumonia diagnosis.

147 We compared the incidence of pneumonia during the baseline period (May 12, 2008, to M

148 6%] vs one [1%]), and Pneumocystis jirovecii pneumonia (eight [5%] vs one [1%]).

149 We identified 32 ventilator-associated pneumonia, eight urinary tract infections, five blood st

150 l pneumonia (including ventilator-associated pneumonia), enrolled at 136 centres in 23 countries, wer

151 ion (p=0.004), and more cumulative bacterial pneumonia episodes (12 month lag only; p trend=0.0004).

152 nagement of Childhood Illness (IMCI)-defined pneumonia episodes in children under 5 years of age.

153 the major analytic challenges in determining pneumonia etiology and review how the common analytical

154 ate a new, integrated analytical approach to pneumonia etiology data.

155 he accurate and meaningful interpretation of pneumonia etiology data.

156 clinical standardization was embedded in the Pneumonia Etiology Research for Child Health (PERCH) stu

157 control selection and present data from the Pneumonia Etiology Research for Child Health (PERCH) stu

158 & Melinda Gates Foundation congratulates the Pneumonia Etiology Research for Child Health (PERCH) stu

159 The Pneumonia Etiology Research for Child Health (PERCH) stu

160 sin gene in children aged 1-59 months in the Pneumonia Etiology Research for Child Health (PERCH) stu

161 The Pneumonia Etiology Research for Child Health (PERCH) stu

162 copy and culture in patients enrolled in the Pneumonia Etiology Research for Child Health (PERCH) stu

163 The Pneumonia Etiology Research for Child Health study was c

164 PERCH (Pneumonia Etiology Research for Child Health) is a case-

165 Over the past century, the focus of pneumonia etiology research has shifted from studies of

166 The future of childhood pneumonia etiology research will likely require integrat

167 in children but has not been widely used in pneumonia etiology studies.

168 ptoms provides the least biased estimates of pneumonia etiology.

169 roup), hypokalaemia (six [6%] and two [4%]), pneumonia (five [5%] and five [11%]), and febrile neutro

170 events (mainly from sepsis, eight [8%]; and pneumonia, five [5%]); four deaths were from adverse eve

171 tansine 2.4 mg/kg weekly group compared with pneumonia (four [4%]), febrile neutropenia (four [4%]),

172 ronchoalveolar lavage (BAL) to differentiate pneumonia from pulmonary shedding.

173 Patients with CMV pneumonia had higher median viral loads (3.9 log10 IU/mL

174 curately determining the causes of childhood pneumonia has remained elusive.

175 se; 0.2%-11.5% of hospitalized patients with pneumonia have been found to have PIV infection.

176 Annual pneumococcal pneumonia hospitalization rates per 100 000 admissions w

177 l regression) to test whether the decline in pneumonia hospitalizations associated with vaccine intro

178 population-based study of community-acquired pneumonia hospitalizations conducted from January 1, 201

179 5, through leading research groups for child pneumonia identified through a comprehensive literature

180 hese 92 patients showed bacterial aspiration pneumonia in 43 patients (46.7%).

181 for acute respiratory distress syndrome was pneumonia in 81% of patients.

182 re commonly used for diagnosing the cause of pneumonia in adults but are rarely performed in children

183 a new standard for detection of pneumococcal pneumonia in adults.

184 osis is a common cause of community-acquired pneumonia in areas of the southwestern United States in

185 for Child Health) is a case-control study of pneumonia in children aged 1-59 months investigating pat

186 ) study, a large study of community-acquired pneumonia in children aged 1-59 months.

187 ulation-based surveillance was for suspected pneumonia in children aged 2-59 months (minimum age 3 mo

188 gnostic accuracy for diagnosing pneumococcal pneumonia in children in 9 African and Asian sites.

189 tion to continuation of open fire cooking on pneumonia in children living in two rural districts, Chi

190 requent in Laos and commonly associated with pneumonia in hospitalized young children.

191 al decline in hospitalizations for all-cause pneumonia in infants in all five countries (average of 2

192 highlighted its potential role as a cause of pneumonia in infants.

193 cross a heterogeneous population with severe pneumonia in low- and middle-income countries has not be

194 g criteria for children with chest indrawing pneumonia in low-resource settings.

195 bioprocessed IgG and protect against lethal pneumonia in mice.

196 sa proteins confer protection against lethal pneumonia in mice.

197 The prevalence of radiographic pneumonia in North American studies was 19% (95% CI, 11%

198 ts, we did not detect a decline in all-cause pneumonia in older adults in any country.

199 pneumonia and negatively associated with RSV pneumonia in PERCH.

200 enesis of childhood acute community-acquired pneumonia in settings with a high tuberculosis burden.

201 As part of the Etiology of Pneumonia in the Community (EPIC) study, children aged <

202 he 2358 children enrolled in the Etiology of Pneumonia in the Community Study with radiographically c

203 We analyzed data from the Etiology of Pneumonia in the Community Study, a multicenter, prospec

204 t tools for patients with community-acquired pneumonia in the emergency department.

205 munity Study with radiographically confirmed pneumonia in the study period; 1019 (71.9%) received bet

206 ed sputum specimens as a diagnostic tool for pneumonia in young children as part of routine clinical

207 omass-fuelled cookstoves reduced the risk of pneumonia in young children in rural Malawi.

208 SP60 and outer membrane protein of chlamydia pneumonia) in stabilizing advanced atherosclerosis in Ap

209 nfection (ARI), especially bronchiolitis and pneumonia, in children worldwide.

210 ning biomass-fuelled cookstoves would reduce pneumonia incidence in young children.

211 gia assessment, with an absolute increase of pneumonia incidence of 1% per day of delay.

212 act of the introduction of these vaccines on pneumonia incidence.

213 mpassing 1961 adults with community-acquired pneumonia included in the German Community-Acquired Pneu

214 e to carbapenems in patients with nosocomial pneumonia (including ventilator-associated pneumonia) ca

215 Adults with nosocomial pneumonia (including ventilator-associated pneumonia), e

216 zidime-avibactam in patients with nosocomial pneumonia, including ventilator-associated pneumonia, co

217 Incidence of all clinical pneumonia increased by 4% (-1 to 8), but hospitalised ca

218 months old were a high-risk group for severe pneumonia, independently of RSV infection.

219 nasal administration and course of influenza pneumonia, inflammatory, and tissue responses were monit

220 Bacterial pneumonia is a significant healthcare burden worldwide.

221 t data suggest that human coronavirus (HCoV) pneumonia is associated with significant mortality in he

222 Nosocomial pneumonia is commonly associated with antimicrobial-resi

223 diabetes in patients with community-acquired pneumonia is largely unknown.

224 ey question is whether the impact of PCVs on pneumonia is similar in low- and high-income populations

225 Ventilator-associated pneumonia is the most important infection in this patien

226 per respiratory tract (URT) of children with pneumonia is unclear.

227 Pneumonia kills more children each year worldwide than a

228 saturation >96%) decreased the likelihood of pneumonia (LR, 0.47 [95% CI, 0.32-0.67]).

229 ld be considered as new policies for empiric pneumonia management are developed.

230 nificance of results may be unclear (ie, the pneumonia may be caused by none, one, some, or all of th

231 een microbiologically confirmed pneumococcal pneumonia (MCPP) cases, cases confirmed for nonpneumococ

232 Microbiologically confirmed pneumococcal pneumonia (MCPP) was confirmed by detection of pneumococ

233 3 years]), 244 with nonspecific interstitial pneumonia (men, 79; women, 165; median age, 60.5 years [

234 During pneumococcal pneumonia, Miwi2-deficient mice exhibited increased expr

235 two isolates exhibited low virulence in the pneumonia model but high virulence in the subcutaneous i

236 n bronchial epithelial cells and in a murine pneumonia model.

237 l in lethal bacteremic sepsis and aspiration pneumonia models of XDR A. baumannii infection.

238 rus (RSV) infection is an important cause of pneumonia mortality in young children.

239 peritonitis (n = 117) or community-acquired pneumonia (n = 126), and of control subjects without sep

240 erase chain reaction [PCR]) compared to "RSV pneumonia" (nasopharyngeal/oropharyngeal or induced sput

241 linical or laboratory findings suggestive of pneumonia (nonpneumonia group).

242 tibiotics, usually for infections other than pneumonia; of the 33 patients whose antibiotics were dis

243 es (development of severe symptoms, clinical pneumonia on/after day 3, or persistent symptoms at day

244 ptoms suggesting either bacterial aspiration pneumonia or non-bacterial aspiration pneumonitis.

245 h Organization-defined severe or very severe pneumonia or were age-frequency-matched community contro

246 ociated with an increased risk of aspiration pneumonia (OR, 1.63; 95% CI, 1.11-2.37).

247 histological diagnosis of usual interstitial pneumonia pattern.

248 Pneumocystis pneumonia (PCP) is a potentially lethal opportunistic in

249 ty of elevated CRP for "confirmed" bacterial pneumonia (positive blood culture or positive lung aspir

250 When acute kidney injury accompanies pneumonia, postdischarge outcomes are worse than either

251 a number of clinical aspects of pneumococcal pneumonia (PP) in children has not been reported.

252 be used to improve estimates of pneumococcal pneumonia prevalence in childhood pneumonia studies.

253 ropriate in settings of very high or low CMV pneumonia prevalence.

254 roving the uptake of first-line Pneumocystis pneumonia prophylaxis in renal transplant recipients.

255 myocardial infarction (r = 0.30; P < 0.01), pneumonia (r = 0.38; P < 0.01), and stroke (r = 0.29; P

256 sociated with chest radiographic evidence of pneumonia (radiographic pneumonia), we compared prevalen

257 In murine models of A. baumannii pneumonia, RAGE signaling alters neither inflammation no

258 art failure, acute myocardial infarction, or pneumonia, reductions in hospital 30-day readmission rat

259 esults were not associated with radiographic pneumonia, regardless of prior antibiotic use, stratific

260 to discriminate between viral and bacterial pneumonia requires further dissection.

261 rt failure, acute myocardial infarction, and pneumonia, respectively.

262 apy was also the best intervention to reduce pneumonia (RR = 0.28; 95% CI, 0.09-0.90), sepsis (RR = 0

263 phagia reduces the risk of stroke-associated pneumonia (SAP), or of how quickly it should be done aft

264 ation guidelines (81.3%), usual interstitial pneumonia secondary to autoimmune conditions (11.5%), or

265 mg/L best discriminated confirmed bacterial pneumonia (sensitivity 77%) from RSV pneumonia (specific

266 tic therapy is the first rank to reduce SSI, pneumonia, sepsis, hospital stay, and antibiotic use.

267 r gastrointestinal haemorrhage (eight [4%]), pneumonia (seven [3%]), gastric haemorrhage (six [3%]),

268 egression analysis showed that intrahospital Pneumonia Severity Index (PSI) class (hazard ratio [HR],

269 of noninvasive ventilation for patients with pneumonia should be cautioned, but targeted enrollment o

270 utropenia (13 [10%]), anaemia (11 [9%]), and pneumonia (six [5%]).

271 cterial pneumonia (sensitivity 77%) from RSV pneumonia (specificity 82%).

272 In pneumonia, specimens are rarely obtained directly from t

273 eumococcal pneumonia prevalence in childhood pneumonia studies.

274 Patients who recover from pneumonia subsequently have elevated rates of death afte

275 rity (66%) of adults with community-acquired pneumonia supported on extracorporeal membrane oxygenati

276 ntially expressed in pediatric patients with pneumonia syndrome attributable to different infections

277 an allo-LS, which was defined as idiopathic pneumonia syndrome or bronchiolitis obliterans syndrome.

278 The pneumonia team at the Bill & Melinda Gates Foundation co

279 mitted with sepsis due to community-acquired pneumonia to 29 ICUs in the UK (second validation cohort

280 ment related, with dyspnoea (three [3%]) and pneumonia (two [2%]) reported most frequently.

281 rom adverse events deemed treatment-related (pneumonia, two [2%]; multiorgan failure, one [1%]; and s

282 hout atypical features of usual interstitial pneumonia (UIP), on high-resolution computed tomography

283 f patients with suspected usual interstitial pneumonia (UIP).

284 est multicountry etiology study of pediatric pneumonia undertaken in the past 3 decades.

285 tibiotics for possible ventilator-associated pneumonia (VAP) do not have pneumonia.

286 Pneumonia virus of mice (PVM) infection has been widely

287 lymphocytic choriomeningitis virus (LCMV) or pneumonia virus of mice (PVM) resulted in rapid and subs

288 immunity during an early-life infection with pneumonia virus of mice (PVM; a murine analogue of RSV).

289 of three doses of PCV13 against radiological pneumonia was an adjusted odds ratio of 0.57 (0.30-1.08)

290 Pneumonia was considered pneumococcal if either sputum G

291 viral load of URT specimens to define viral pneumonia was equivocal.

292 ographic evidence of pneumonia (radiographic pneumonia), we compared prevalence and density in IS spe

293 load could provide evidence of causality of pneumonia, we compared viral load in the URT of children

294 ons for HF, 1229939 for AMI, and 2544530 for pneumonia were identified at 5016, 4772, and 5057 hospit

295 ryngeal swabs from children with and without pneumonia were tested using quantitative real-time polym

296 important risk factor for community-acquired pneumonia, whereas the prevalence of undiagnosed diabete

297 brosis (CF) and can cause severe necrotizing pneumonia, which is often fatal.

298 1) acute kidney injury, 2) pneumonia, and 3) pneumonia with acute kidney injury.

299 rimary endpoint was WHO-defined radiological pneumonia with pulmonary consolidation.

300 us aureus plays an important role in sepsis, pneumonia, wound infections, and cystic fibrosis (CF), w